Infectious Disease Therapeutics Market Size and Forecast (2020-2030)

According to our latest study on ” Infectious Disease Therapeutics Market Forecast to 2030 – Global Analysis – Drug Class, Indication, Route of Administration, and Distribution Channel,” the infectious disease therapeutics market was valued at US$ 119.708 billion in 2022 and is expected to reach US$ 167.883 billion by 2030. The market is estimated to register a CAGR of 4.3% from 2022 to 2030. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.

Infectious diseases can transfer from one person to another through direct or indirect contact. Patients must take medications with anti-infective properties to treat infectious diseases. Pathogens such as bacteria, fungi, viruses, and parasites are the primary cause of these disorders. To target the organism causing the sickness and implement a remedy, the host’s defensive system is directly targeted.

The growing incidence of infectious diseases is anticipated to increase the sales of infectious disease therapeutics drugs in developing countries. Asia Pacific has become an adaptable and business-friendly hub due to moderately fewer data requirements and stringent regulations. In addition, high investments in health research and life science in emerging countries play a key role in promoting the latest technologies in developing countries, which, in turn, supports the inclination toward infectious disease diagnosis and treatment. For instance, UNAIDS is advocating for an investment of US$ 29 billion by 2025 to meet the needs of low- and middle-income countries to prevent and treat AIDS. In India, South Korea, Brazil, and Mexico, there is a high prevalence of infectious diseases such as Hepatitis, HAI, HIV, and influenza; a large population of patients; a rise in disposable income of the population; improved infrastructure of healthcare; and growing medical tourism. Thus, crucial infectious disease therapeutics product manufacturers in emerging infectious disease therapeutics markets in these countries are expected to witness lucrative opportunities in the future.

Pfizer Inc., Gilead Sciences Inc., F. Hoffmann-La Roche Ltd, Shionogi & Co Ltd, Bayer AG, BioCryst Pharmaceuticals Inc., GSK Plc, AbbVie Inc, Merck & Co Inc., and Astellas Pharma Inc are among the key players operating in the global infectious disease therapeutics market.

The report segments the global infectious disease therapeutics market as follows:

The infectious disease therapeutics market is segmented based on drug class, indication, route of administration, and distribution channel. The infectious disease therapeutics market is subsegmented by drug class into anti-viral, anti-bacterial, anti-fungal, and others. Based on indication, the infectious disease therapeutics market is segmented into HIV, hepatitis, tuberculosis, influenza, HPV, and others. Regarding route of administration, the infectious disease therapeutics market is segmented into oral, parenteral, topical, and others. The infectious disease therapeutics market, by distribution channel, is categorized into hospital pharmacies, retail pharmacies, and others. The infectious disease therapeutics market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, Rest of South & Central America).

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Infectious Disease Therapeutics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Infectious Disease Therapeutics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Infectious Disease Therapeutics Market – Key Market Dynamics
5.1 Infectious Disease Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Infectious Disease
5.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics
5.3 Market Restraints
5.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects
5.4 Market Opportunities
5.4.1 Growing Opportunities in Developing Nations
5.5 Future Trends
5.5.1 Rising Number of Product Approvals and Launches
5.6 Impact of Drivers and Restraints:
6. Infectious Disease Therapeutics Market – Global Market Analysis
6.1 Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
7. Infectious Disease Therapeutics Market Analysis – by Drug Class
7.1 Overview
7.2 Anti-Viral
7.2.1 Overview
7.2.2 Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Anti-bacterial
7.3.1 Overview
7.3.2 Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Anti-fungal
7.4.1 Overview
7.4.2 Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8. Infectious Disease Therapeutics Market Analysis – by Indication
8.1 Overview
8.2 HIV
8.2.1 Overview
8.2.2 HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hepatitis
8.3.1 Overview
8.3.2 Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tuberculosis
8.4.1 Overview
8.4.2 Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 HPV
8.6.1 Overview
8.6.2 HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9. Infectious Disease Therapeutics Market Analysis – by Route of Administration
9.1 Overview
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Topical
9.4.1 Overview
9.4.2 Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10. Infectious Disease Therapeutics Market Analysis – by Distribution Channel
10.1 Overview
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Retail Pharmacies
10.3.1 Overview
10.3.2 Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11. Infectious Disease Therapeutics Market – Geographical Analysis
11.1 North America: Infectious Disease Therapeutics Market
11.1.1 Overview
11.1.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.1.2.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.1.2.4 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.2 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.2.1 Overview
11.1.3.3 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.3.1 United States: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.3.2 United States: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.3.3 United States: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.3.4 United States: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.4 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.4.1 Overview
11.1.3.5 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.5.1 Canada: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.5.2 Canada: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.5.3 Canada: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.5.4 Canada: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.6 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.6.1 Overview
11.1.3.7 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.7.1 Mexico: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.7.2 Mexico: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.7.3 Mexico: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.7.4 Mexico: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2 Europe: Infectious Disease Therapeutics Market
11.2.1 Overview
11.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.2.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.2.2.4 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.2 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.2.1 Overview
11.2.3.3 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.3.1 Germany: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.3.2 Germany: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.3.3 Germany: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.3.4 Germany: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.4 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.4.1 Overview
11.2.3.5 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.5.1 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.5.2 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.5.3 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.5.4 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.6 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.6.1 Overview
11.2.3.7 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.7.1 France: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.7.2 France: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.7.3 France: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.7.4 France: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.8 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.8.1 Overview
11.2.3.9 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.9.1 Italy: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.9.2 Italy: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.9.3 Italy: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.2.3.9.4 Italy: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.10 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.10.1 Overview
11.2.3.11 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.11.1 Spain: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.11.2 Spain: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.11.3 Spain: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.11.4 Spain: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.12 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.12.1 Overview
11.2.3.13 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.13.1 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.13.2 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.13.3 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.13.4 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3 Asia Pacific: Infectious Disease Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.2.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.3.2.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.2 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.2.1 Overview
11.3.3.3 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 China: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.3.2 China: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.3.3 China: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.3.4 China: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.4 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.4.1 Overview
11.3.3.5 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 Japan: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.5.2 Japan: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.5.3 Japan: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.5.4 Japan: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.6 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.6.1 Overview
11.3.3.7 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 India: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.7.2 India: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.7.3 India: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.7.4 India: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.8 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.8.1 Overview
11.3.3.9 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Australia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.9.2 Australia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.9.3 Australia: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.9.4 Australia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.10 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.10.1 Overview
11.3.3.11 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 South Korea: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.11.2 South Korea: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.11.3 South Korea: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.11.4 South Korea: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.12 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.12.1 Overview
11.3.3.13 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.13.1 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.13.2 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.13.3 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.13.4 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4 Middle East & Africa Infectious Disease Therapeutics Market
11.4.1 Overview
11.4.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.4.2.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.4 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.2 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 Overview
11.4.3.3 Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.3.2 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.3.3 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.3.4 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.4 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 Overview
11.4.3.5 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.5.2 South Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.5.3 South Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.5.4 South Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.6 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Overview
11.4.3.7 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.7.2 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.7.3 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.7.4 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.8 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.8.1 Overview
11.4.3.9 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.9.1 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.9.2 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.9.3 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.9.4 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5 South and Central America: Infectious Disease Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.5.2.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.4 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.2 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.2.1 Overview
11.5.3.3 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.3.1 Brazil: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.3.2 Brazil: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.3.3 Brazil: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.3.4 Brazil: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.4 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.4.1 Overview
11.5.3.5 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.5.1 Argentina: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.5.2 Argentina: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.5.3 Argentina: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.5.4 Argentina: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.6 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.6.1 Overview
11.5.3.7 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.7.1 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.7.2 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.7.3 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.7.4 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
12. Infectious Disease Therapeutics Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Infectious Disease Therapeutics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Pfizer Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Shionogi & Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioCryst Pharmaceuticals Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GSK Plc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AbbVie Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck & Co Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Astellas Pharma Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners

Table 1. Infectious Disease Therapeutics Market Segmentation
Table 2. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Drug Class
Table 3. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Indication
Table 4. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 5. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 6. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 7. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 8. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 10. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 12. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 13. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 15. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 16. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 17. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 18. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 19. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 20. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 21. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 22. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 23. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 24. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 25. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 26. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 27. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 28. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 29. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 30. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 31. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 32. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 33. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 34. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 35. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 36. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 37. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 38. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 40. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 41. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 42. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 43. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 44. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 45. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 46. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 47. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 48. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 49. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 50. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 51. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 52. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 53. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 54. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 55. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 56. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 57. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 58. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 59. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 60. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 61. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 62. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 63. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 65. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 66. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 67. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 68. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 69. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 70. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 71. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 72. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 73. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 74. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 75. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 76. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 78. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 79. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 80. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 81. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 82. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 83. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 84. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 85. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 86. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 87. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 88. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 90. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 91. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 92. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 93. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 94. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 95. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 96. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 97. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 98. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 99. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 100. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 101. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 103. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 104. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 105. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 106. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 107. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 108. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 109. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 110. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 111. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 112. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 113. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 114. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 115. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 116. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 117. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 118. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel

Figure 1. Infectious Disease Therapeutics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
Figure 5. Global Eye Drops Market, By Geography Forecast Analysis, 2022 & 2030
Figure 6. Infectious Disease Therapeutics Market Share (%) – by Drug Class (2022 and 2030)
Figure 7. Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Infectious Disease Therapeutics Market Share (%) – by Indication (2022 and 2030)
Figure 12. HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Disease Therapeutics Market Share (%) – by Route Of Administration (2022 and 2030)
Figure 19. Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Infectious Disease Therapeutics Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 24. Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. North America: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 30. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Europe: Infectious Disease Therapeutics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 34. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Europe: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 36. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 42. Asia Pacific: Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 44. Asia Pacific: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 45. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 51. Middle East & Africa: Infectious Disease Therapeutics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 52. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 53. Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 54. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 57. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 58. South & Central America: Infectious Disease Therapeutics Market, By Key Country – Revenue (2022) (US$ Million)
Figure 59. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 60. South and Central America: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 61. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 62. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 63. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)